BamSEC and AlphaSense Join Forces
Learn More

RVL Pharmaceuticals plc – Material Contracts

Formerly OTC: RVLPQ

Material Contracts Filter

EX-10.1
from 8-K 9 pages Settlement Term Sheet
12/34/56
EX-10.1
from 8-K 42 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 9 pages Third Amendment to Note Purchase Agreement
12/34/56
EX-10.26
from 10-K 7 pages ​ Second Amendment to Note Purchase Agreement
12/34/56
EX-10.5
from 10-Q 20 pages Share Subscription Agreement
12/34/56
EX-10.4
from 10-Q 20 pages Share Subscription Agreement
12/34/56
EX-10.3
from 10-Q 21 pages Share Subscription Agreement
12/34/56
EX-10.2
from 10-Q 21 pages Share Subscription Agreement
12/34/56
EX-10.1
from 10-Q 139 pages First Amendment to Note Purchase Agreement
12/34/56
EX-10.1
from 8-K 5 pages First Amendment to License Agreement
12/34/56
EX-10.14
from 10-K 3 pages Brian Markison ​ Dear Brian,
12/34/56
EX-10.13
from 10-K 25 pages Employment Agreement
12/34/56
EX-10.11
from 10-K 15 pages ​ RVL Pharmaceuticals plc Amended and Restated 2018 Incentive Plan
12/34/56
EX-10.10
from 10-K 18 pages Amended and Restated RVL Pharmaceuticals plc 2016 Equity Incentive Plan Amended and Restated Effective as of August 14, 2018 ​
12/34/56
EX-10.8
from 10-K 11 pages ​ RVL Pharmaceuticals plc Amended and Restated 2018 Employee Share Purchase Plan ​ ​
12/34/56
EX-10.7
from 10-K 5 pages RVL Pharmaceuticals plc 2018 Incentive Plan Non-Statutory Stock Option Agreement ​
12/34/56
EX-10.1
from 8-K 2 pages [Remainder of Page Intentionally Left Blank.]
12/34/56
EX-10.2
from 8-K 19 pages Share Subscription Agreement
12/34/56
EX-10.1
from 8-K 133 pages Note Purchase Agreement Dated as of October 1, 2021 Among Osmotica Pharmaceutical Corp., as the Issuer, Osmotica Holdings US LLC, as Intermediate Holdings, Osmotica Pharmaceuticals Plc, as Super Holdings, Certain Subsidiaries of Super Holdings, as the Guarantors, Athyrium Opportunities IV Acquisition LP, as the Administrative Agent and the Purchasers From Time to Time Party Hereto
12/34/56
EX-10.1
from 8-K 28 pages Contingent Amendment Agreement
12/34/56